Alice Blue Home
URL copied to clipboard

Trending News

Dhanlaxmi Crop Science IPO Wraps Up with Massive 528.90x Subscription – Highlights Unveiled!

Dhanlaxmi Crop Science IPO concluded on a high note, achieving an impressive 528.90x subscription, reflecting strong investor interest and robust demand in the market.
Dhanlaxmi Crop Science IPO Closes Strong with 528.90x Subscription, Marking Investor Confidence!
Dhanlaxmi Crop Science IPO Closes Strong with 528.90x Subscription, Marking Investor Confidence!

Dhanlaxmi Crop Science Limited IPO closed successfully, garnering an extraordinary 528.90x subscription. This remarkable response highlights the strong demand and investor confidence in the company’s growth potential, marking it as a significant milestone in the market.

Alice Blue Image

Dhanlaxmi Crop Science Limited IPO Subscription Status

Dhanlaxmi Crop Science IPO achieved a remarkable 61.71x subscription on its second day, showcasing strong market enthusiasm and investor confidence in the company’s growth potential.

How to check Dhanlaxmi Crop Science IPO Subscription Status?

Steps to check Dhanlaxmi Crop Science Limited IPO subscription status on NSE

Following are the steps to check it through the NSE website

  • Visit NSE‘s official website.
  • Navigate to the ‘Market Data’ tab.
  • Choose ‘IPO’.
  • Select the ‘Dhanlaxmi Crop Science Limited IPO’ to check its subscription status.
  • Opt for either NSE Bid details or Consolidated Bid details.
  • Explore the total number of bids received from various investors. 
Alice Blue Image

Dhanlaxmi Crop Science Limited IPO Allotment Status

The allotment date for the Dhanlaxmi Crop Science Limited IPO is set for December12, with shares priced from ₹52 to ₹55 per share and a face value of ₹10. The offering consists of lots of 2000 shares, with bids accepted for these lots or their multiples.

Dhanlaxmi Crop Science Limited IPO Listing Date 

Dhanlaxmi Crop Science Limited IPO is expected to be listed on the NSE SME on December 16, 2024.

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.

Loading
Read More News